203 related articles for article (PubMed ID: 2572975)
1. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):285-92. PubMed ID: 2572975
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT1D receptors.
Hoyer D; Schoeffter P; Waeber C; Palacios JM
Ann N Y Acad Sci; 1990; 600():168-81; discussion 181-2. PubMed ID: 2252308
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
Pauwels PJ; Palmier C
Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
[TBL] [Abstract][Full Text] [Related]
5. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889
[TBL] [Abstract][Full Text] [Related]
6. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
Schoeffter P; Waeber C; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):602-8. PubMed ID: 3216894
[TBL] [Abstract][Full Text] [Related]
7. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
Zgombick JM; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies.
Waeber C; Schoeffter P; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):479-85. PubMed ID: 2533324
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra.
Hoyer D; Schoeffter P
Eur J Pharmacol; 1988 Feb; 147(1):145-7. PubMed ID: 3371410
[No Abstract] [Full Text] [Related]
10. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
11. L-694,247: a potent 5-HT1D receptor agonist.
Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
[TBL] [Abstract][Full Text] [Related]
13. Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in Chinese hamster lung fibroblasts and opossum renal epithelial cells.
Pauwels PJ; Palmier C
J Pharmacol Exp Ther; 1994 Sep; 270(3):938-45. PubMed ID: 7932206
[TBL] [Abstract][Full Text] [Related]
14. How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):135-8. PubMed ID: 2552330
[TBL] [Abstract][Full Text] [Related]
15. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
16. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
Waldmeier PC; Williams M; Baumann PA; Bischoff S; Sills MA; Neale RF
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.
Bruinvels AT; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):569-82. PubMed ID: 8361548
[TBL] [Abstract][Full Text] [Related]
18. SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
Schoeffter P; Fozard JR; Stoll A; Siegl H; Seiler MP; Hoyer D
Eur J Pharmacol; 1993 Feb; 244(3):251-7. PubMed ID: 8384569
[TBL] [Abstract][Full Text] [Related]
19. Serotonin inhibits adenylate cyclase in human platelet membranes.
Newman ME
Eur J Pharmacol; 1992 Aug; 226(4):281-5. PubMed ID: 1397059
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT1B receptors.
Middlemiss DN; Hutson PH
Ann N Y Acad Sci; 1990; 600():132-47; discussion 347-48. PubMed ID: 2252306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
